Biography
I am a South African medical doctor with research experience as a site investigator in various clinical trials including TB vaccine trials. Currently, I work as a sponsor medical expert in the TB Treatment Unit of the LMU Institute of Tropical and Infectious Diseases in Munich, Germany. My role focuses on clinical oversight and supporting implementation of early-phase tuberculosis treatment trials.
Key Impacts
An AI chest X-ray severity score is prognostic of time to culture conversion in a pulmonary TB clinical trial
An AI-generated CXR severity score at baseline offers a potentially powerful tool to identify patients at risk of delayed culture conversion. These findings, collected in a trial setting, highlight the tool’s potential for early risk stratification in treatment of pulmonary TB, with the additional benefit of improving consistency in data collection within multi-site studies.
Source: Conference 2024